HIGHLIGHTS
- who: Yun Liu from the (UNIVERSITY) have published the research: Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy, in the Journal: (JOURNAL)
- what: Perspective, the research progress of dualtarget VEGFR inhibitors is summarized, focusing on the rational targets selection, structure-activity relationships (SARs) and pharmacological activities of dual-target VEGFR inhibitors. This approach is characterized by integrating the potency of two selective inhibitors into a single molecule and is carried out by linking or merging the pivotal pharmacophores of selected maternal inhibitors.
- how: As shown . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.